MRC Clinical Trials Unit at UCL
Menu
Home
About
Our Structure
Our People
History
Our Environmental Commitment
News
Research
Cancer
ARCHERY
REFINE
Add-Aspirin
STAMPEDE
RAMPART
STOPCAP M1
UKCTOCS
Open Studies
Past Studies
Infections
Studies by Research Area
Neurodegenerative Diseases
OCTOPUS
ACORD collaboration
Methodology
Design
Conduct
Analysis
Meta-analysis
Software
Other Research & Policy
Data Sharing
Publications
Studies in other areas
Briefing Papers
Regulatory information, Toolkits & Templates
Our podcast
Studies
All Studies
Studies Search
Patients & Public
About Clinical Trials
What is a clinical trial?
What is a randomised clinical trial?
What is an observational study?
How do we make sure a trial is safe?
How is a trial designed and run?
What happens at the end of a trial?
Taking Part in a Clinical Trial
How can you take part in a trial?
What questions should you ask before participating in a trial?
Patient and Public Involvement
About our PPI group
Our PPI Strategy
PPI Resources
Study & Careers
Capacity Strengthening
Enhancing skills of trial teams we work with across the globe
Improving the clinical trials ecosystem
NIHR Associate Principal Investigator (PI) Scheme
Contact
Search the site
Trials using biomarkers to assign patients to treatment for bowel cancer
21 May 2014
Further information:
British Journal of Cancer paper
FOCUS-3 study page
FOCUS4 study page
FOCUS4 website
All News Items
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Home
News
News Stories
2014
May
Trials using biomarkers to assign patients to treatment for bowel cancer